Zhang Hong-Xia, Liu Shu-Juan, Tang Xiao-Lu, Duan Guo-Li, Ni Xin, Zhu Xiao-Yan, Liu Yu-Jian, Wang Chang-Nan
School of Kinesiology, The key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport, Shanghai, China.
Cell Physiol Biochem. 2016;40(6):1603-1612. doi: 10.1159/000453210. Epub 2016 Dec 23.
Hydrogen sulfide (H2S), known as the third endogenous gaseous transmitter, has received increasing attention because of its diverse effects, including angiogenesis, vascular relaxation and myocardial protection.We aimed to investigate the role of H2S in oxidative/nitrative stress and inflammation in acute lung injury (ALI) induced by endotoxemia.
Male ICR mice were divided in six groups: (1) Control group; (2) GYY4137treatment group; (3) L-NAME treatment group; (4) lipopolysaccharide (LPS) treatment group; (5) LPS with GYY4137 treatment group; and (6) LPS with L-NAME treatment group. The lungs were analysed by histology, NO production in the mouse lungs determined by modified Griess (Sigma-Aldrich) reaction, cytokine levels utilizing commercialkits, and protein abundance by Western blotting.
GYY4137, a slowly-releasing H2S donor, improved the histopathological changes in the lungs of endotoxemic mice. Treatment with NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, increased anti-oxidant biomarkers such as thetotal antioxidant capacity (T-AOC) and theactivities of catalase (CAT) and superoxide dismutase (SOD) but decreased a marker of peroxynitrite (ONOO-) action and 3-nitrotyrosine (3-NT) in endotoxemic lung. L-NAME administration also suppressed inflammation in endotoxemic lung, as evidenced by the decreased pulmonary levels of interleukin (IL)-6, IL-8, and myeloperoxidase (MPO) and the increased level of anti-inflammatory cytokine IL-10. GYY4137 treatment reversed endotoxin-induced oxidative/nitrative stress, as evidenced by a decrease in malondialdehyde (MDA), hydrogenperoxide (H2O2) and 3-NT and an increase in the antioxidant biomarker ratio of reduced/oxidized glutathione(GSH/GSSG ratio) and T-AOC, CAT and SOD activity. GYY4137 also attenuated endotoxin-induced lung inflammation. Moreover, treatment with GYY4137 inhibited inducible NOS (iNOS) expression and nitric oxide (NO) production in the endotoxemia lung.
GYY4137 conferred protection against acute endotoxemia-associated lung injury, which may have beendue to the anti-oxidant, anti-nitrative and anti-inflammatory properties of GYY4137. The present findings warrant further exploration of the clinical applicability of H2S in the prevention and treatment of ALI.
硫化氢(H₂S)作为第三种内源性气体递质,因其具有多种作用,包括血管生成、血管舒张和心肌保护等,而受到越来越多的关注。我们旨在研究H₂S在由内毒素血症诱导的急性肺损伤(ALI)中的氧化/硝化应激及炎症反应中的作用。
将雄性ICR小鼠分为六组:(1)对照组;(2)GYY4137治疗组;(3)L-NAME治疗组;(4)脂多糖(LPS)治疗组;(5)LPS与GYY4137联合治疗组;(6)LPS与L-NAME联合治疗组。通过组织学分析肺组织,采用改良Griess(Sigma-Aldrich)反应测定小鼠肺组织中一氧化氮(NO)的生成,使用商业试剂盒检测细胞因子水平,并通过蛋白质印迹法检测蛋白质丰度。
GYY4137是一种缓释H₂S供体,可改善内毒素血症小鼠肺组织的组织病理学变化。一氧化氮合酶(NOS)抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)治疗可增加内毒素血症小鼠肺组织中的抗氧化生物标志物,如总抗氧化能力(T-AOC)、过氧化氢酶(CAT)和超氧化物歧化酶(SOD)的活性,但可降低过氧亚硝酸根(ONOO⁻)作用标志物和3-硝基酪氨酸(3-NT)的水平。L-NAME给药还可抑制内毒素血症小鼠肺组织中的炎症反应,表现为肺组织中白细胞介素(IL)-6、IL-8和髓过氧化物酶(MPO)水平降低以及抗炎细胞因子IL-10水平升高。GYY4137治疗可逆转内毒素诱导的氧化/硝化应激,表现为丙二醛(MDA)、过氧化氢(H₂O₂)和3-NT水平降低,以及抗氧化生物标志物还原型/氧化型谷胱甘肽比值(GSH/GSSG比值)、T-AOC、CAT和SOD活性升高。GYY4137还可减轻内毒素诱导的肺组织炎症。此外,GYY4137治疗可抑制内毒素血症小鼠肺组织中诱导型NOS(iNOS)的表达和一氧化氮(NO)的生成。
GYY4137可对急性内毒素血症相关的肺损伤起到保护作用,这可能归因于GYY4137的抗氧化、抗硝化和抗炎特性。本研究结果值得进一步探索H₂S在ALI预防和治疗中的临床适用性。